^
    over2years
    GPC3-CAR-T Cells for the Hepatocellular Carcinoma (clinicaltrials.gov)
    P1, N=12, Suspended, Beijing Tsinghua Chang Gung Hospital | Not yet recruiting --> Suspended
    Trial suspension • CAR T-Cell Therapy
    |
    GPC3 (Glypican 3)
    |
    GPC3 positive
    |
    GPC3-CAR-T Cells
    over3years
    GPC3-CAR-T Cells for the Hepatocellular Carcinoma (clinicaltrials.gov)
    P1, N=12, Not yet recruiting, Beijing Tsinghua Chang Gung Hospital | Trial completion date: Nov 2022 --> Oct 2023 | Initiation date: Aug 2020 --> Sep 2021 | Trial primary completion date: Aug 2022 --> Jun 2023
    Clinical • Trial completion date • Trial initiation date • Trial primary completion date • CAR T-Cell Therapy
    |
    GPC3 (Glypican 3)
    |
    GPC3 positive
    |
    GPC3-CAR-T Cells